Effect of recombinant human insulin-like growth factor-1 on the inflammatory response to acute renal injury

Journal of the American Society of Nephrology

Volumn 7, Issue 5, 1996, Pages 710-720

  Goes, Nelson ^a   Urmson, Joan ^a   Vincent, Dianne ^a   Ramassar, Vidyanand ^a   Halloran, Philip F ^a,b  

^a UNIVERSITY OF ALBERTA   (Canada)

^b UNIVERSITY OF ALBERTA   (Canada)

Author keywords

Acute renal failure; Inflammation; Insulin like growth factor 1; Ischemia; MHC

Indexed keywords

CYTOKINE; EPIDERMAL GROWTH FACTOR; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 1; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 2; MESSENGER RNA; MONOCLONAL ANTIBODY; RECOMBINANT SOMATOMEDIN C; TUMOR NECROSIS FACTOR ALPHA;

ACUTE KIDNEY FAILURE; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; IMMUNOHISTOLOGY; KIDNEY INTERSTITIUM; KIDNEY ISCHEMIA; KIDNEY TRANSPLANTATION; MALE; MOUSE; NEPHRITIS; NONHUMAN; NORTHERN BLOTTING; PRIORITY JOURNAL; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION;

EID: 0030357269     PISSN: 10466673     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (53)

1. Madrenas J, Parfrey NA, Halloran PF: Interferon gamma-mediated renal MHC expression in mercuric chloride-induced glomerulonephritis. Kidney Int 1991;39:273-281.
2. Shoskes D, Parfrey NA, Halloran PF: Increased major histocompatibility complex antigen expression in unilateral ischemic acute tubular necrosis in the mouse. Transplantation 1990;49:201-207.
3. Goes N, Urmson J, Ramassar V, Halloran PF: Ischemic acute tubular necrosis induces an extensive local cytokine response: Evidence for induction of Interferon-γ, transforming growth factor β-1, granulocyte-macrophage colony-stimulating factor, interleukin-2 and interleukin-10. Transplantation 1995;59:565-572.
4. Safirstein R, Price PM, Saggi SJ, Harris RC: Changes in gene expression after temporary renal ischemia. Kidney Int 1990;37:1515-1521.
5. Goes N, Sims T, Urmson J, Vincent D, Ramassar V, Halloran PF: Disturbed MHC regulation in the interferon-gamma knockout mouse. J Immunol 1995;155: 4559-4566.
6. Matzinger P. Tolerance, danger, and the extended family. In: Paul WE, Fathman CG, Metzger H, eds. Annual Reviews in Immunology, 12th ed. Palo Alto, CA: Annual Reviews Inc.; 1994:991.
7. Lim EC, Terasaki PI. Early graft function. In: Terasaki P, Cecka JM, eds. Clinical Transplants 1991. Los Angeles: UCLA Tissue Typing Laboratory; 1991:401.
8. Halloran PF, Aprile MA, Farewell V, et al.: Early function as the principal correlate of graft survival: A multivariate analysis of 200 cadaveric renal transplants treated with a protocol incorporating antilymphocyte globulin and cyclosporine. Transplantation 1988;46:223-228.
9. Kawaida K, Matsumoto K, Shimazu H, Nakamura T: Hepatocyte growth factor prevents acute renal failure and accelerates renal regeneration in mice. Proc Natl Acad Sci USA 1994;91:4357-4361.
10. Humes HD, Cieslinski DA, Coimbra TM, Messana JM, Galvao C: Epidermal growth factor enhances renal tubule cell regeneration and repair and accelerates the recovery of renal function in postischemic acute renal failure. J Clin Invest 1989;84:1757-1761.
11. Ding H, Kopple JD, Cohen A, Hirschberg R: Recombinant human insulin-like growth factor-1 accelerates recovery and reduces catabolism in rats with ischemic acute renal failure. J Clin Invest 1993;91:2281-2287.
12. Sekido N, Makaida N, Harada A, Nakanishi I, Watanabe Y, Matsushima K: Prevention of lung reperfusion injury by rabbits by a monoclonal antibody against interleukin-8. Nature (Lond) 1993;365:654-657.
13. Kelly KJ, Williams WW Jr, Colvin RB, Bonventre JV: Antibody to intercellular adhesion molecule 1 protects the kidney against ischemic kidney. Proc Natl Acad Sci USA 1994;91:812-816.
14. Nolte D, Hecht R, Schmid P: Role of Mac-1 and ICAM-1 in ischemia-reperfusion injury in a microcirculation model of BALB/c mice. Am J Physiol 1994;267:H1320-H1328.
15. Sharar SR, Mihelcic DD, Han KT, Harlan JM, Winn RK: Ischemia reperfusion injury in the rabbit ear is reduced by both immediate and delayed CD18 leukocyte adherence blockade. J Immunol 1994;153:2234-2238.
16. Salacinski PRP, McLean C, Sykes JEC, Clements-Jones W, Lowry PJ: Iodination of proteins, glycoproteins, and peptides using a solid-phase oxidizing agent, 1,3,4,6-tetrachloro-3,6-diphenyl glycoluril (Iodogen). Anal Biochem 1981;17:136-146.
17. Miller SB, Martin DR, Kissane J, Hammerman MR: Insulin-like growth factor I accelerates recovery from ischemic acute tubular necrosis in the rat. Proc Natl Acad Sci USA 1992;89:11876-11880.
18. Jephthah-Ochola J, Urmson J, Farkas S, Halloran PF: Regulation of MHC in vivo. Bacterial lipopolysaccharide induces class I and II MHC products in mouse tissues by a T cell independent, cyclosporine sensitive mechanism. J Immunol 1988;141:792-800.
19. Cockfield SM, Ramassar V, Urmson J, Halloran PF: Multiple low dose streptozotocin induces systemic MHC expression in mice by triggering T cells to release IFN-γ. J Immunol 1989;142:1120-1128.
20. Halloran PF, Urmson J, Ramassar V, Laskin C, Autenried P: Increased class I and class II MHC products and mRNA in kidneys of MRL-lpr/lpr mice during autoimmune nephritis and inhibition by cyclosporine. J Immunol 1988;141:2303-2312.
21. Chirgwin JM, Pryzybyla AE, MacDonald RJ, Rutter WJ: Isolation of biologically active ribonucleic acid from sources enriched in ribonuclease. Biochemistry 1979; 18:5294-5299.
22. Glisin V, Crkvenjakov R, Byus C: Ribonucleic acid isolated by cesium chloride centrifugation. Biochemistry 1974;13:2633-2637.
23. Gray PW, Goeddel DV: Cloning and expression of murine immune interferon cDNA. Proc Natl Acad Sci USA 1983; 80:5842-5846.
24. Broski AP, Halloran PF: Tissue distribution of IL-10 mRNA in normal mice: Expression in T and B cells independent and increased by irradiation. Transplantation 1994;57:582-592.
25. Strachan T, Sodoyer R, Damotte M, Jordan BR: Complete nucleotide sequence of a functional class I HLA gene, HLA-A3: Implications for the evolution of HLA genes. EMBO (Eur Mol Biol Organ) J 1984;3:887-894.
26. Davis MM, Cohen DI, Nielsen M, Steinmetz M, Paul WE, Hood L: Cell type specific cDNA probes and the murine I region: The localization and orientation of α. Proc Natl Acad Sci USA 1984;81:2194-2198.
27. Gray A, Dull TJ, Ullrich A: Nucleotide sequence of epidermal growth factor cDNA predicts a 128:000-molecular weight protein precursor. Nature (Lond) 1983; 303:722-725.
28. Feinberg AP, Vogelstein B: A technique for radiolabelling DNA restriction endonuclease fragments to high specific activity. Anal Biochem 1983;132:6-13.
29. Jolly DJ, Okayama H, Berg P: Isolation and characterization of a full-length expressible cDNA for human hypoxanthine phosphoribosyltransferase. Proc Natl Acad Sci USA 1983;80:477-481.
30. Miller SB, Martin DR, Kissane J, Hammerman MR: Rat models for clinical use of insulin-like growth factor 1 in acute renal failure. Am J Physiol 1994;266:F949-F956.
31. Safirstein R: Gene expression in nephrotoxic and ischemic acute renal failure. J Am Soc Nephrol 1994;4:1387-1395.
32. Lennard TWJ, Parrott NR, Wilson RG, et al.: Primary nonfunction after renal transplantation: A prospective multifactorial analysis of possible causes in 106 consecutive transplants. Transplant Proc 1988;20:439-441.
33. Troppmann C, Almond PS, Payne WD: Does acute tubular necrosis affect renal transplant outcome? The impact of rejection episodes. Transplant Proc 1993;25: 905.
34. Müller CA, Markovic-Lipovski J, Risler T, Bohle A, Müller GA: Expression of HLA-DQ, -DR, and -DP antigens in normal kidney and glomerulonephritis. Kidney Int 1989;35:116-124.
35. Sinclair GD, Wadgymar A, Halloran PF, Delovitch TL: Graft-vs-host reactions induce H-2 class II gene transcription in host kidney cells. Immunogenetics 1984;20: 503-511.
36. 1 disease with anti-1-A monoclonal antibodies. J Exp Med 1983;158:1350-1355.
37. Yokoyama H, Zheng X, Strom TB, Rubin Kelley V: B7+-transfectant tubular epithelial cells induce T cell anergy, ignorance or proliferation. Kidney Int 1994;45: 1105-1112.
38. Dallman MJ, Wood KJ, Morris PJ: Specific cytotoxic T cells are found in the nonrejected kidneys of blood-transfused rats. J Exp Med 1988;165:566-571.
39. Wood KJ, Hopley A, Dallman MJ, Morris PJ: Lack of correlation between the induction of donor class I and class II major histocompatibility complex antigens and graft rejection. Transplantation 1988;45:759-767.
40. Dallman MJ, Wood KJ, Morris PJ: Specific cytotoxic T cells are found in the nonrejected kidneys of blood-transfused rats. J Exp Med 1987;165:566-571.
41. Friedlaender M, Popovtzer MM, Weiss O, Nefesh I, Kopolovic J, Raz I: Insulin-like growth factor-1 (IGF-1) enhances recovery from HgC12-induced acute renal failure: The effects on renal IGF-1, IGF-1 receptor, and IGF-binding protein-1 mRNA. J Am Soc Nephrol 1995;5: 1782-1791.
42. Manzo CB, Dickerson RN, Settle RG, Rajter JJ: Insulin-like growth factor 1 and endotoxin-mediated kidney dysfunction in critically ill, parenterally fed rats. Nutrition 1993;9:528-531.
43. Steinhardt GF, Liapis H, Phillips B, Vogler G, Nag M, Yoon KW: Insulin-like growth factor improves renal architecture of fetal kidneys with complete ureteral obstruction. J Urol 1995;154:690-693.
44. Bondy CA, Underwood LE, Clemmons DR, Guler HP, Bach MA, Skarulis M: Clinical uses of insulin-like growth factor 1. Ann Intern Med 1994;120:593-601.
45. Hirschberg R, Brunori G, Kopple JD, Guler HP: Effects of insulin-like growth factor 1 on renal function in normal men. Kidney Int 1993;43:387-397.
46. Jaffa AA, LeRoith D, Roberts CT Jr, Rust PF, Mayfield RK: Insulin-like growth factor 1 produces renal hyperfiltration by a kinin-mediated mechanism. Am J Physiol 1994;266:F102-F107.
47. Kolaczynski JW, Caro JF: Insulin-like growth factor-1 therapy in diabetes: Physiologic basis, clinical benefits, and risks. Ann Intern Med 1994;120:47-55.
48. Inishi Y, Okuda T, Arakawa T, Kurokawa K: Insulin attenuates intracellular calcium responses and cell contraction caused by vasoactive agents. Kidney Int 1994; 45:1318-1325.
49. Tsukahara H, Gordienko DV, Tonshoff B, Gelato MC, Goligorsky MS: Direct demonstration of insulin-like growth factor-1-induced nitric oxide production by endothelial cells. Kidney Int 1994;45:598-604.
50. Lin J-J, Cybulsky AV, Goodyer PR, Fine RN, Kaskel FJ: Insulin-like growth factor-1 enhances epidermal growth factor receptor activation and renal tubular cell regeneration in postischemic acute renal failure. J Lab Clin Med 1995;125:724-733.
51. Abrass CK, Spicer D, Raugi GJ: Induction of nodular sclerosis by insulin in rat mesangial cells in vitro: Studies of collagen. Kidney Int 1995;47:25-37.
52. Mehls O, Irzynjec T, Ritz E, Eden S, Kovács G, Klaus G, Floege J, Mall G: Effects of rhGH and rhIGF-1 on renal growth and morphology. Kidney Int 1993;44:1251-1258.
53. Yao D-L, Liu X, Hudson LD, Webster HF: Insulin-like growth factor I treatment reduces demyelination and up-regulates gene expression of myelin-related proteins in experimental autoimmune encephalomyelitis. Proc Natl Acad Sci USA 1995;92:6190-6194.